These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29733226)

  • 21. Efficacy and Safety of Long-Term Use of Dienogest in Women With Ovarian Endometrioma.
    Lee SR; Yi KW; Song JY; Seo SK; Lee DY; Cho S; Kim SH
    Reprod Sci; 2018 Mar; 25(3):341-346. PubMed ID: 29161960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dienogest in the treatment of endometriosis: systematic review.
    Andres Mde P; Lopes LA; Baracat EC; Podgaec S
    Arch Gynecol Obstet; 2015 Sep; 292(3):523-9. PubMed ID: 25749349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dienogest: a review of its use in the treatment of endometriosis.
    McCormack PL
    Drugs; 2010 Nov; 70(16):2073-88. PubMed ID: 20964453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dienogest for Treatment of Endometriosis in Women: A 28-Week, Open-Label, Extension Study.
    Yu Q; Zhang S; Li H; Wang P; Zvolanek M; Ren X; Dong L; Lang J
    J Womens Health (Larchmt); 2019 Feb; 28(2):170-177. PubMed ID: 30461337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dienogest 2 mg Daily in the Treatment of Adolescents with Clinically Suspected Endometriosis: The VISanne Study to Assess Safety in ADOlescents.
    Ebert AD; Dong L; Merz M; Kirsch B; Francuski M; Böttcher B; Roman H; Suvitie P; Hlavackova O; Gude K; Seitz C
    J Pediatr Adolesc Gynecol; 2017 Oct; 30(5):560-567. PubMed ID: 28189702
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relief of uterine bleeding by cyclic administration of dienogest for endometriosis.
    Yanase T; Tsuneki I; Tamura M; Kurabayashi T
    Gynecol Endocrinol; 2014 Nov; 30(11):804-7. PubMed ID: 25060125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative, open-label prospective study on the quality of life and sexual function of women affected by endometriosis-associated pelvic pain on 2 mg dienogest/30 µg ethinyl estradiol continuous or 21/7 regimen oral contraceptive.
    Caruso S; Iraci M; Cianci S; Fava V; Casella E; Cianci A
    J Endocrinol Invest; 2016 Aug; 39(8):923-31. PubMed ID: 27023105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety of Dienogest and Other Hormonal Treatments for Endometriosis in Real-World Clinical Practice (VIPOS): A Large Noninterventional Study.
    Heinemann K; Imthurn B; Marions L; Gerlinger C; Becker K; Moehner S; Faustmann T
    Adv Ther; 2020 May; 37(5):2528-2537. PubMed ID: 32301063
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dienogest versus continuous oral levonorgestrel/EE in patients with endometriosis: what's the best choice?
    Piacenti I; Viscardi MF; Masciullo L; Sangiuliano C; Scaramuzzino S; Piccioni MG; Muzii L; Benedetti Panici P; Porpora MG
    Gynecol Endocrinol; 2021 May; 37(5):471-475. PubMed ID: 33650928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing the Effect of Dienogest and OCPS on Pain and Quality of Life in Women with Endometriosis: A Randomized, Double-Blind, Placebo-Controlled Trial.
    Niakan G; Rokhgireh S; Ebrahimpour M; Mehdizadeh Kashi A
    Arch Iran Med; 2021 Sep; 24(9):670-677. PubMed ID: 34816682
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced pelvic pain in women with endometriosis: efficacy of long-term dienogest treatment.
    Petraglia F; Hornung D; Seitz C; Faustmann T; Gerlinger C; Luisi S; Lazzeri L; Strowitzki T
    Arch Gynecol Obstet; 2012 Jan; 285(1):167-73. PubMed ID: 21681516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The dienogest-related cystitis in women with endometriosis: a prospective, controlled, comparative study.
    Krakhotkin DV; Silkina MN; Chernylovskyi VA; Gayvoronskaya SA
    J Obstet Gynaecol; 2022 Aug; 42(6):2492-2497. PubMed ID: 35653789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the efficacy of diegnogest and levonorgestrel-releasing intrauterine system after laparoscopic surgery for endometriosis.
    Lee KH; Jung YW; Song SY; Kang BH; Yang JB; Ko YB; Lee M; Han HY; Yoo HJ
    J Obstet Gynaecol Res; 2018 Sep; 44(9):1779-1786. PubMed ID: 29974633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of dienogest in endometriosis: a narrative literature review and expert commentary.
    Murji A; Biberoğlu K; Leng J; Mueller MD; Römer T; Vignali M; Yarmolinskaya M
    Curr Med Res Opin; 2020 May; 36(5):895-907. PubMed ID: 32175777
    [No Abstract]   [Full Text] [Related]  

  • 35. The Efficacy of Dienogest in Reducing Disease and Pain Recurrence After Endometriosis Surgery: a Systematic Review and Meta-Analysis.
    Muzii L; Di Tucci C; Galati G; Carbone F; Palaia I; Bogani G; Perniola G; Tomao F; Kontopantelis E; Di Donato V
    Reprod Sci; 2023 Nov; 30(11):3135-3143. PubMed ID: 37217824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dienogest vs GnRH agonists as postoperative therapy after laparoscopic eradication of deep infiltrating endometriosis with bowel and parametrial surgery: a randomized controlled trial.
    Ceccaroni M; Clarizia R; Liverani S; Donati A; Ceccarello M; Manzone M; Roviglione G; Ferrero S
    Gynecol Endocrinol; 2021 Oct; 37(10):930-933. PubMed ID: 34036845
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of dienogest over 53 weeks for the treatment of endometriosis.
    Sugimoto K; Nagata C; Hayashi H; Yanagida S; Okamoto A
    J Obstet Gynaecol Res; 2015 Dec; 41(12):1921-6. PubMed ID: 26369271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A dose-ranging study to determine the efficacy and safety of 1, 2, and 4mg of dienogest daily for endometriosis.
    Köhler G; Faustmann TA; Gerlinger C; Seitz C; Mueck AO
    Int J Gynaecol Obstet; 2010 Jan; 108(1):21-5. PubMed ID: 19819448
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment of endometriosis with dienogest: preliminary report].
    Kamiński K; Fiegler P; Marr J; Moore C
    Ginekol Pol; 2001 May; 72(5):299-304. PubMed ID: 11526761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Postoperative administration of dienogest for suppressing recurrence of disease and relieving pain in subjects with ovarian endometriomas.
    Adachi K; Takahashi K; Nakamura K; Otake A; Sasamoto N; Miyoshi Y; Shioji M; Yamamoto Y; Fujitani M; Wakimoto A; Tokuhira A; Kobayashi E; Yoshimura A; Sawada K; Kimura T
    Gynecol Endocrinol; 2016 Aug; 32(8):646-649. PubMed ID: 26890948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.